Your session is about to expire
← Back to Search
Other
Trim II for Noninvasive Lipolysis and Circumference Reduction of Abdomen.
N/A
Waitlist Available
Research Sponsored by InMode MD Ltd.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
No Placebo-Only Group
Summary
This trial will test a waist-worn device called Trim II that aims to reduce belly fat and waist size without surgery. It targets adults aged 18-70 who want a non-invasive solution. The device works by breaking down fat cells, which are then naturally removed by the body.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Evaluation of Change in Abdomen Circumference Using Tape Measurements in cm at the 3 Months Follow-up Visit Comparing to Baseline.
Safety of the Trim II Treatment for Lipolysis and Abdominal Circumference Reduction.
Secondary study objectives
Change in Abdominal Fat Thickness Measured by Ultrasound Imaging (USI) at the 3 Months Follow-up Visit Comparing to Baseline.
Percentage of Participants With Baseline and 3 Month Abdomen Photographs Correctly Identified by Two Blind Evaluators
Subject's Satisfaction With Study Treatment at 3 Months Follow-up Visit.
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: treatmentExperimental Treatment1 Intervention
3 bi-weekly treatments
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Trim II
2021
N/A
~80
Find a Location
Who is running the clinical trial?
InMode MD Ltd.Lead Sponsor
24 Previous Clinical Trials
1,315 Total Patients Enrolled